A carregar...
The SUMO Pathway in Hematomalignancies and Their Response to Therapies
SUMO (Small Ubiquitin-related MOdifier) is a post-translational modifier of the ubiquitin family controlling the function and fate of thousands of proteins. SUMOylation is deregulated in various hematological malignancies, where it participates in both tumorigenesis and cancer cell response to thera...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721055/ https://ncbi.nlm.nih.gov/pubmed/31405039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20163895 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|